PT  - JOURNAL ARTICLE
AU  - Hansson, Jonas
AU  - Govaert, Alain
AU  - Pates, Richard
AU  - Tegling, Emma
AU  - Soltesz, Kristian
TI  - Fundamental limitations of case isolation
AID  - 10.1101/2021.03.31.21254677
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.31.21254677
4099  - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254677.short
4100  - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254677.full
AB  - Case isolation is a strategy with the potential to curb infectious disease epidemics. Expressions for the stability boundary of a case isolation scheme defined through the proportion of the infectious population that it isolates with a given delay have recently been established. Here we quantify how this stability boundary moves when heterogeneity of the inter-individual contact network increases, and explain the underlying mechanism through insightful examples.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by the Swedish Research Council (grants 2017-04989, 2019-00691) and by the Wallenberg AI, Autonomous Systems and Software Program (WASP) funded by the Knut and Alice Wallenberg Foundation. The authors are members of the ELLIIT Strategic Research Area at Lund University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A